Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts
Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim of this study is to describe a group of patients who died with TB (active disease or sequelae) and COVID-19 in two cohorts. Data from 49 consecutive cases in 8 countries (cohort A) and 20 hospitalised patients...
Uloženo v:
| Vydáno v: | Pediatric pulmonology Ročník 26; číslo 4; s. 233 - 240 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Spain
Elsevier España, S.L.U
01.07.2020
Informa UK Limited Wiley Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U Taylor & Francis Group |
| Témata: | |
| ISSN: | 2531-0437, 2531-0429, 8755-6863, 2531-0437, 1099-0496 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim of this study is to describe a group of patients who died with TB (active disease or sequelae) and COVID-19 in two cohorts.
Data from 49 consecutive cases in 8 countries (cohort A) and 20 hospitalised patients with TB and COVID-19 (cohort B) were analysed and patients who died were described. Demographic and clinical variables were retrospectively collected, including co-morbidities and risk factors for TB and COVID-19 mortality.
Overall, 8 out of 69 (11.6%) patients died, 7 from cohort A (14.3%) and one from cohort B (5%).
Out of 69 patients 43 were migrants, 26/49 (53.1%) in cohort A and 17/20 (85.0%) in cohort B.
Migrants: (1) were younger than natives; in cohort A the median (IQR) age was 40 (27–49) VS. 66 (46–70) years, whereas in cohort B 37 (27–46) VS. 48 (47–60) years; (2) had a lower mortality rate than natives (1/43, 2.3% versus 7/26, 26.9%; p-value: 0.002); (3) had fewer co-morbidities than natives (23/43, 53.5% versus 5/26–19.2%) natives; p-value: 0.005).
The study findings show that: (1) mortality is likely to occur in elderly patients with co-morbidities; (2) TB might not be a major determinant of mortality and (3) migrants had lower mortality, probably because of their younger age and lower number of co-morbidities. However, in settings where advanced forms of TB frequently occur and are caused by drug-resistant strains of M. tuberculosis, higher mortality rates can be expected in young individuals. |
|---|---|
| AbstractList | AbstractLittle is known about the relationship between the COVID-19 and tuberculosis (TB). The aim of this study is to describe a group of patients who died with TB (active disease or sequelae) and COVID-19 in two cohorts. Data from 49 consecutive cases in 8 countries (cohort A) and 20 hospitalised patients with TB and COVID-19 (cohort B) were analysed and patients who died were described. Demographic and clinical variables were retrospectively collected, including co-morbidities and risk factors for TB and COVID-19 mortality. Overall, 8 out of 69 (11.6%) patients died, 7 from cohort A (14.3%) and one from cohort B (5%). Out of 69 patients 43 were migrants, 26/49 (53.1%) in cohort A and 17/20 (85.0%) in cohort B. Migrants: (1) were younger than natives; in cohort A the median (IQR) age was 40 (27–49) VS. 66 (46–70) years, whereas in cohort B 37 (27–46) VS. 48 (47–60) years; (2) had a lower mortality rate than natives (1/43, 2.3% versus 7/26, 26.9%; p-value: 0.002); (3) had fewer co-morbidities than natives (23/43, 53.5% versus 5/26–19.2%) natives; p-value: 0.005). The study findings show that: (1) mortality is likely to occur in elderly patients with co-morbidities; (2) TB might not be a major determinant of mortality and (3) migrants had lower mortality, probably because of their younger age and lower number of co-morbidities. However, in settings where advanced forms of TB frequently occur and are caused by drug-resistant strains of M. tuberculosis, higher mortality rates can be expected in young individuals. Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim of this study is to describe a group of patients who died with TB (active disease or sequelae) and COVID-19 in two cohorts.Data from 49 consecutive cases in 8 countries (cohort A) and 20 hospitalised patients with TB and COVID-19 (cohort B) were analysed and patients who died were described. Demographic and clinical variables were retrospectively collected, including co-morbidities and risk factors for TB and COVID-19 mortality.Overall, 8 out of 69 (11.6%) patients died, 7 from cohort A (14.3%) and one from cohort B (5%).Out of 69 patients 43 were migrants, 26/49 (53.1%) in cohort A and 17/20 (85.0%) in cohort B.Migrants: (1) were younger than natives; in cohort A the median (IQR) age was 40 (27–49) VS. 66 (46–70) years, whereas in cohort B 37 (27–46) VS. 48 (47–60) years; (2) had a lower mortality rate than natives (1/43, 2.3% versus 7/26, 26.9%; p-value: 0.002); (3) had fewer co-morbidities than natives (23/43, 53.5% versus 5/26–19.2%) natives; p-value: 0.005).The study findings show that: (1) mortality is likely to occur in elderly patients with co-morbidities; (2) TB might not be a major determinant of mortality and (3) migrants had lower mortality, probably because of their younger age and lower number of co-morbidities. However, in settings where advanced forms of TB frequently occur and are caused by drug-resistant strains of M. tuberculosis, higher mortality rates can be expected in young individuals. Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim of this study is to describe a group of patients who died with TB (active disease or sequelae) and COVID-19 in two cohorts. Data from 49 consecutive cases in 8 countries (cohort A) and 20 hospitalised patients with TB and COVID-19 (cohort B) were analysed and patients who died were described. Demographic and clinical variables were retrospectively collected, including co-morbidities and risk factors for TB and COVID-19 mortality. Overall, 8 out of 69 (11.6%) patients died, 7 from cohort A (14.3%) and one from cohort B (5%). Out of 69 patients 43 were migrants, 26/49 (53.1%) in cohort A and 17/20 (85.0%) in cohort B. Migrants: (1) were younger than natives; in cohort A the median (IQR) age was 40 (27–49) VS. 66 (46–70) years, whereas in cohort B 37 (27–46) VS. 48 (47–60) years; (2) had a lower mortality rate than natives (1/43, 2.3% versus 7/26, 26.9%; p-value: 0.002); (3) had fewer co-morbidities than natives (23/43, 53.5% versus 5/26–19.2%) natives; p-value: 0.005). The study findings show that: (1) mortality is likely to occur in elderly patients with co-morbidities; (2) TB might not be a major determinant of mortality and (3) migrants had lower mortality, probably because of their younger age and lower number of co-morbidities. However, in settings where advanced forms of TB frequently occur and are caused by drug-resistant strains of M. tuberculosis, higher mortality rates can be expected in young individuals. Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim of this study is to describe a group of patients who died with TB (active disease or sequelae) and COVID-19 in two cohorts. Data from 49 consecutive cases in 8 countries (cohort A) and 20 hospitalised patients with TB and COVID-19 (cohort B) were analysed and patients who died were described. Demographic and clinical variables were retrospectively collected, including co-morbidities and risk factors for TB and COVID-19 mortality. Overall, 8 out of 69 (11.6%) patients died, 7 from cohort A (14.3%) and one from cohort B (5%). Out of 69 patients 43 were migrants, 26/49 (53.1%) in cohort A and 17/20 (85.0%) in cohort B. Migrants: (1) were younger than natives; in cohort A the median (IQR) age was 40 (27-49) VS. 66 (46-70) years, whereas in cohort B 37 (27-46) VS. 48 (47-60) years; (2) had a lower mortality rate than natives (1/43, 2.3% versus 7/26, 26.9%; p-value: 0.002); (3) had fewer co-morbidities than natives (23/43, 53.5% versus 5/26-19.2%) natives; p-value: 0.005). The study findings show that: (1) mortality is likely to occur in elderly patients with co-morbidities; (2) TB might not be a major determinant of mortality and (3) migrants had lower mortality, probably because of their younger age and lower number of co-morbidities. However, in settings where advanced forms of TB frequently occur and are caused by drug-resistant strains of M. tuberculosis, higher mortality rates can be expected in young individuals.Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim of this study is to describe a group of patients who died with TB (active disease or sequelae) and COVID-19 in two cohorts. Data from 49 consecutive cases in 8 countries (cohort A) and 20 hospitalised patients with TB and COVID-19 (cohort B) were analysed and patients who died were described. Demographic and clinical variables were retrospectively collected, including co-morbidities and risk factors for TB and COVID-19 mortality. Overall, 8 out of 69 (11.6%) patients died, 7 from cohort A (14.3%) and one from cohort B (5%). Out of 69 patients 43 were migrants, 26/49 (53.1%) in cohort A and 17/20 (85.0%) in cohort B. Migrants: (1) were younger than natives; in cohort A the median (IQR) age was 40 (27-49) VS. 66 (46-70) years, whereas in cohort B 37 (27-46) VS. 48 (47-60) years; (2) had a lower mortality rate than natives (1/43, 2.3% versus 7/26, 26.9%; p-value: 0.002); (3) had fewer co-morbidities than natives (23/43, 53.5% versus 5/26-19.2%) natives; p-value: 0.005). The study findings show that: (1) mortality is likely to occur in elderly patients with co-morbidities; (2) TB might not be a major determinant of mortality and (3) migrants had lower mortality, probably because of their younger age and lower number of co-morbidities. However, in settings where advanced forms of TB frequently occur and are caused by drug-resistant strains of M. tuberculosis, higher mortality rates can be expected in young individuals. |
| Author | Centis, R. Stochino, C. García-García, J.-M. Migliori, G.B. Sánchez-Montalvá, A. Gualano, G. Tadolini, M. Villa, S. Sotgiu, G. Spanevello, A. Tabernero, E. Motta, I. D’Ambrosio, L. Lipani, F. Pontali, E. van den Boom, M. Goletti, D. Visca, D. Palmieri, F. |
| Author_xml | – sequence: 1 givenname: I. surname: Motta fullname: Motta, I. organization: Dipartimento di Scienze Mediche, Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia, Torino, Italy – sequence: 2 givenname: R. surname: Centis fullname: Centis, R. organization: Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy – sequence: 3 givenname: L. surname: D’Ambrosio fullname: D’Ambrosio, L. organization: Public Health Consulting Group, Lugano, Switzerland – sequence: 4 givenname: J.-M. surname: García-García fullname: García-García, J.-M. organization: Tuberculosis Research Programme (PII-TB), SEPAR, Barcelona, Spain – sequence: 5 givenname: D. surname: Goletti fullname: Goletti, D. organization: Translational Research Unit, National Institute for Infectious Diseases ‘L. Spallanzani’, IRCCS, Rome, Italy – sequence: 6 givenname: G. surname: Gualano fullname: Gualano, G. organization: Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases ‘L. Spallanzani’, IRCCS, Rome, Italy – sequence: 7 givenname: F. surname: Lipani fullname: Lipani, F. organization: Dipartimento di Scienze Mediche, Clinica Universitaria Malattie Infettive, Ospedale Amedeo di Savoia, Torino, Italy – sequence: 8 givenname: F. surname: Palmieri fullname: Palmieri, F. organization: Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases ‘L. Spallanzani’, IRCCS, Rome, Italy – sequence: 9 givenname: A. surname: Sánchez-Montalvá fullname: Sánchez-Montalvá, A. organization: Infectious Diseases Department. International Health and Tuberculosis Unit, Vall d’Hebron University Hospital, Spain – sequence: 10 givenname: E. surname: Pontali fullname: Pontali, E. organization: Department of Infectious Diseases, Galliera Hospital, Genova, Italy – sequence: 11 givenname: G. surname: Sotgiu fullname: Sotgiu, G. organization: Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy – sequence: 12 givenname: A. surname: Spanevello fullname: Spanevello, A. organization: Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy – sequence: 13 givenname: C. surname: Stochino fullname: Stochino, C. organization: Phthisiology Unit, E.-Morelli Sondalo Hospital, ASST Valtellina and Alto Lario, Sondrio, Italy – sequence: 14 givenname: E. surname: Tabernero fullname: Tabernero, E. organization: Servicio Neumología, Hospital de Cruces, Bilbao, Spain – sequence: 15 givenname: M. surname: Tadolini fullname: Tadolini, M. organization: Unit of Infectious Diseases, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy – sequence: 16 givenname: M. surname: van den Boom fullname: van den Boom, M. organization: World Health Organization Regional office for Europe, Copenhagen, Denmark – sequence: 17 givenname: S. surname: Villa fullname: Villa, S. organization: Centre for Multidisciplinary Research in Health Science, University of Milan, Milan, Italy – sequence: 18 givenname: D. surname: Visca fullname: Visca, D. organization: Division of Pulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS, Tradate, Italy – sequence: 19 givenname: G.B. surname: Migliori fullname: Migliori, G.B. email: giovannibattista.migliori@icsmaugeri.it organization: Servizio di Epidemiologia Clinica delle Malattie Respiratorie, Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy |
| BackLink | https://cir.nii.ac.jp/crid/1872835442659485056$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/32411943$$D View this record in MEDLINE/PubMed https://u-picardie.hal.science/hal-04162817$$DView record in HAL |
| BookMark | eNqFU11rFDEUHaRia-0_EJkHHxTc9eZrZlJEKPWjC4UKVl9DJsnsZs1MtsnMyv57M7uttgVZCElIzj335N6T59lB5zuTZS8RTBGg4v1yuhpc680UA4YpsCkAfpIdYUbQBCgpD-7tD7OTGJeQEGmQCj3LDgmmCHFKjrL2eqhNUIPz0cZ3-fnVz9mnCeK57HTe2nmQXR9P82_BONvaToZNupFuk8C5b3JtZL9IO6WGEGw3z22XFzxfyd6aFJg3wbd5_9vnyi986OOL7GkjXTQnt-tx9uPL5-vzi8nl1dfZ-dnlRJVF0U9Uw7jWNaJgNCG8UaARInXNpNQKKiW5bhiqyrqoWKWplqqijNdAtWGEMEOOs9mOV3u5FKtg26RceGnF9sCHuZCht8oZwSutMWpKrjmnTVXwEhQymELFtKKEJq6PO67VULdGq_SwIN0D0oc3nV2IuV-LEuP0ApwI3u4IFo_CLs4uxXgGFBW4QuUaJeyb22TB3wwm9qK1URnnZGf8EEXSRYEhYCxBX93X9Zf5rrcJcLoDqOBjDKYRyvapM36UaZ1AIEYviVSgrZfE6CUBTMBWNH0UfMe_J-z1LqyzNqUb59QnXBFGKS4YpxUDVvyrqUkmWFsTRFTJMcpoG4zqU5fsvjyPCZRL2ZR0v8zGxKUfQrJpFEhELEB8Hz_D-BcwEEBAxuJ8-D_B_vx_AC03GA8 |
| CitedBy_id | crossref_primary_10_1183_20734735_0079_2021 crossref_primary_10_1016_j_imj_2025_100169 crossref_primary_10_1016_j_ijtb_2024_04_005 crossref_primary_10_1183_13993003_00925_2023 crossref_primary_10_1080_23744235_2020_1806353 crossref_primary_10_1080_07853890_2022_2160491 crossref_primary_10_1016_j_imu_2022_100849 crossref_primary_10_1016_j_dsx_2020_07_034 crossref_primary_10_1016_j_rmed_2020_106204 crossref_primary_10_1016_j_ijtb_2020_08_019 crossref_primary_10_3390_idr15060068 crossref_primary_10_1007_s10528_023_10563_x crossref_primary_10_1080_16549716_2021_1927332 crossref_primary_10_1007_s12038_025_00496_5 crossref_primary_10_1155_2020_1401053 crossref_primary_10_3201_eid2611_203163 crossref_primary_10_7759_cureus_11734 crossref_primary_10_1186_s12879_022_07519_8 crossref_primary_10_1016_j_ijregi_2025_100673 crossref_primary_10_1016_j_pulmoe_2022_01_018 crossref_primary_10_1055_s_0043_1778667 crossref_primary_10_1108_IJOPH_09_2020_0067 crossref_primary_10_3389_fimmu_2022_882651 crossref_primary_10_1016_j_pulmoe_2021_08_002 crossref_primary_10_1016_j_ijid_2021_02_090 crossref_primary_10_37689_acta_ape_2021AR02115 crossref_primary_10_1183_13993003_02665_2020 crossref_primary_10_1128_spectrum_03075_22 crossref_primary_10_1016_j_arbres_2020_11_016 crossref_primary_10_1183_13993003_01998_2020 crossref_primary_10_1016_j_cegh_2022_101044 crossref_primary_10_1016_j_pulmoe_2022_01_016 crossref_primary_10_3389_fimmu_2025_1586789 crossref_primary_10_52692_1857_0011_2021_3_71_31 crossref_primary_10_1016_j_pulmoe_2020_12_016 crossref_primary_10_1183_13993003_01708_2020 crossref_primary_10_3389_fimmu_2023_1254206 crossref_primary_10_3389_fmed_2022_971008 crossref_primary_10_3389_fimmu_2022_909011 crossref_primary_10_1002_jcla_24151 crossref_primary_10_1111_imr_12963 crossref_primary_10_1016_j_jiph_2020_07_003 crossref_primary_10_1002_jmv_26740 crossref_primary_10_1016_j_isci_2022_104464 crossref_primary_10_7717_peerj_18041 crossref_primary_10_1016_j_pulmoe_2020_10_005 crossref_primary_10_4103_jehp_jehp_142_21 crossref_primary_10_1016_j_pulmoe_2020_12_012 crossref_primary_10_1183_13993003_03408_2020 crossref_primary_10_1183_13993003_01718_2020 crossref_primary_10_3390_idr17010011 crossref_primary_10_1590_s2175_97902022e20741 crossref_primary_10_3346_jkms_2025_40_e38 crossref_primary_10_1515_hmbci_2020_0096 crossref_primary_10_2147_JMDH_S463859 crossref_primary_10_19127_bshealthscience_944827 crossref_primary_10_3389_fimmu_2024_1424374 crossref_primary_10_1183_13993003_02538_2021 crossref_primary_10_1002_jmv_26868 crossref_primary_10_1183_13993003_01369_2020 crossref_primary_10_1183_23120541_00562_2020 crossref_primary_10_1016_j_pulmoe_2020_08_006 crossref_primary_10_1007_s40808_022_01430_6 crossref_primary_10_12688_f1000research_53385_1 crossref_primary_10_1016_j_arbres_2023_09_002 crossref_primary_10_3389_fpubh_2024_1413604 crossref_primary_10_3390_tropicalmed7090247 crossref_primary_10_1097_MD_0000000000041999 crossref_primary_10_1002_ccr3_4233 crossref_primary_10_2147_IDR_S370837 crossref_primary_10_1007_s10096_024_04918_4 crossref_primary_10_1128_AAC_01436_21 crossref_primary_10_1590_0102_311x00094520 crossref_primary_10_4103_ijmy_ijmy_56_21 crossref_primary_10_4103_lungindia_lungindia_544_20 crossref_primary_10_3389_fmed_2021_740593 crossref_primary_10_1007_s15010_021_01576_y crossref_primary_10_1007_s12648_025_03577_1 crossref_primary_10_1093_cid_ciaa1198 crossref_primary_10_1183_13993003_01727_2020 crossref_primary_10_3390_pharmaceutics13122041 crossref_primary_10_1016_j_radcr_2022_01_063 crossref_primary_10_3389_fmicb_2021_747827 crossref_primary_10_1016_j_jmh_2021_100041 crossref_primary_10_3390_tropicalmed6020081 crossref_primary_10_1016_j_ijid_2022_03_026 crossref_primary_10_1055_s_0042_1760409 crossref_primary_10_1183_13993003_02710_2020 crossref_primary_10_1016_j_ijid_2023_03_021 crossref_primary_10_1016_j_arbres_2022_07_006 crossref_primary_10_1016_j_chaos_2021_111486 crossref_primary_10_1590_1806_9282_20230661 crossref_primary_10_1038_s41467_022_35689_1 crossref_primary_10_7759_cureus_54687 crossref_primary_10_1007_s00726_021_02958_0 crossref_primary_10_21292_2075_1230_2022_100_5_7_12 crossref_primary_10_1371_journal_pone_0275658 crossref_primary_10_3390_jpm13010116 crossref_primary_10_1007_s40324_023_00330_8 crossref_primary_10_1371_journal_pone_0252712 crossref_primary_10_3390_ijms25189971 crossref_primary_10_1016_j_arbres_2022_07_013 crossref_primary_10_3390_tropicalmed6020074 crossref_primary_10_1186_s12879_024_09947_0 crossref_primary_10_3390_jcm12144784 crossref_primary_10_1016_j_rmr_2020_09_006 crossref_primary_10_1038_s41577_021_00579_y crossref_primary_10_1016_j_heliyon_2023_e18726 crossref_primary_10_3390_diagnostics11101768 crossref_primary_10_1177_20499361211016973 crossref_primary_10_1183_13993003_02328_2020 crossref_primary_10_1183_20734735_0176_2021 crossref_primary_10_7189_jogh_15_04192 crossref_primary_10_4103_INJMS_INJMS_72_20 crossref_primary_10_1007_s42770_021_00677_y crossref_primary_10_1016_j_nmni_2021_100910 crossref_primary_10_1183_13993003_01786_2021 crossref_primary_10_1093_inthealth_ihaf011 crossref_primary_10_3390_ijms22073773 crossref_primary_10_3390_ijms242216315 crossref_primary_10_3389_fmed_2021_657006 crossref_primary_10_1186_s12879_020_05450_4 crossref_primary_10_3390_tropicalmed7060083 crossref_primary_10_1016_j_ijid_2022_02_043 crossref_primary_10_1016_j_tube_2020_102020 crossref_primary_10_1016_j_rmcr_2022_101653 crossref_primary_10_1371_journal_pone_0259006 crossref_primary_10_1080_23744235_2023_2245885 crossref_primary_10_1016_S2213_2600_22_00092_3 crossref_primary_10_2147_IDR_S433695 crossref_primary_10_1186_s12879_025_11093_0 crossref_primary_10_3389_fcimb_2023_1140548 crossref_primary_10_1177_20420986211041277 crossref_primary_10_1016_j_pulmoe_2021_02_002 crossref_primary_10_1016_j_jinf_2024_106314 crossref_primary_10_7759_cureus_19882 crossref_primary_10_1155_2021_5313832 crossref_primary_10_31482_mmsl_2022_017 crossref_primary_10_23946_2500_0764_2022_7_1_78_85 crossref_primary_10_1136_bmjopen_2021_059396 crossref_primary_10_1016_j_pulmoe_2020_05_013 |
| Cites_doi | 10.1183/13993003.01260-2020 10.1056/NEJMoa2002032 10.5588/ijtld.20.0124 10.1183/13993003.01522-2019 10.1183/13993003.02328-2020 10.3389/fmicb.2019.02752 10.1016/S0140-6736(20)30211-7 10.1016/j.ijid.2019.03.036 10.1136/bmj.m606 10.1016/S0140-6736(20)30566-3 10.1183/13993003.00632-2020 |
| ContentType | Journal Article |
| Contributor | Global tuberculosis network (GTN) CHU Amiens-Picardie Agents infectieux, résistance et chimiothérapie - UR UPJV 4294 (AGIR ) ; Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie Alma Mater Studiorum Università di Bologna = University of Bologna (UNIBO) Università degli Studi di Milano = University of Milan (UNIMI) |
| Contributor_xml | – sequence: 1 fullname: Alma Mater Studiorum Università di Bologna = University of Bologna (UNIBO) – sequence: 2 fullname: Università degli Studi di Milano = University of Milan (UNIMI) – sequence: 3 fullname: Agents infectieux, résistance et chimiothérapie - UR UPJV 4294 (AGIR ) ; Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie – sequence: 4 fullname: CHU Amiens-Picardie – sequence: 5 fullname: Global tuberculosis network (GTN) |
| Copyright | 2020 Sociedade Portuguesa de Pneumologia Sociedade Portuguesa de Pneumologia Copyright © 2020 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License 2020 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. 2020 Sociedade Portuguesa de Pneumologia |
| Copyright_xml | – notice: 2020 Sociedade Portuguesa de Pneumologia – notice: Sociedade Portuguesa de Pneumologia – notice: Copyright © 2020 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved. – notice: Distributed under a Creative Commons Attribution 4.0 International License – notice: 2020 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. 2020 Sociedade Portuguesa de Pneumologia |
| DBID | 6I. AAFTH RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC 5PM DOA |
| DOI | 10.1016/j.pulmoe.2020.05.002 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CiNii Complete CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Open Access Full Text url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2531-0437 1099-0496 |
| EndPage | 240 |
| ExternalDocumentID | oai_doaj_org_article_98dd21f79d994f86970c1e24085dc434 PMC7221402 oai:HAL:hal-04162817v1 32411943 10_1016_j_pulmoe_2020_05_002 S2531043720301033 1_s2_0_S2531043720301033 |
| Genre | Journal Article |
| GroupedDBID | .1- .FO 0R~ 1P~ 65R AAEDW AALRI AAXUO AAYWO ABMAC ACLIJ ACVFH ADBBV ADCNI ADVLN AEUPX AEXQZ AFPUW AFRHN AFTJW AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ BCNDV EBS EJD FDB GROUPED_DOAJ M4Z OK1 ROL SSZ TDBHL Z5R AACTN AFCTW NCXOZ 6I. AAFTH AQTUD RYH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 --- .3N .GA .GJ .Y3 05W 10A 123 1L6 1OB 1OC 1XC 1ZS 31~ 33P 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHQN AAIPD AAMMB AAMNL AANHP AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCZN ACGFS ACGOF ACMXC ACPOU ACRPL ACSCC ACXBN ACXQS ACYXJ ADBTR ADEOM ADIZJ ADKYN ADMGS ADNMO ADOZA ADXAS ADZMN AEFGJ AEIGN AEIMD AENEX AEUYR AEYWJ AFBPY AFFNX AFFPM AFGKR AFWVQ AFZJQ AGHNM AGQPQ AGXDD AGYGG AHBTC AHMBA AIACR AIDQK AIDYY AIQQE AITYG AIURR ALAGY ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 DUUFO EMOBN F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO RJQFR RX1 RYL SAMSI SUPJJ TEORI UB1 V2E W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WVDHM WXI WXSBR XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT 5PM |
| ID | FETCH-LOGICAL-c766t-cf59ddb140ed339fc0d113bb5aadc08ca9df5187b6858d4dac8459b04de5335e3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 182 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000547603700009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2531-0437 2531-0429 8755-6863 |
| IngestDate | Mon Nov 03 22:08:27 EST 2025 Tue Nov 04 01:47:30 EST 2025 Tue Oct 14 20:23:49 EDT 2025 Wed Oct 01 14:56:38 EDT 2025 Thu Apr 03 07:00:13 EDT 2025 Sat Nov 29 08:05:56 EST 2025 Tue Nov 18 22:00:39 EST 2025 Mon Nov 10 09:07:22 EST 2025 Sun Apr 06 06:53:10 EDT 2025 Sun Feb 23 10:18:49 EST 2025 Tue Aug 26 18:40:54 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | COVID-19 Migrants Sequelae Mortality TB Infection control |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2020 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c766t-cf59ddb140ed339fc0d113bb5aadc08ca9df5187b6858d4dac8459b04de5335e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-1085-0442 0000-0002-3595-9903 0000-0002-2809-6230 0000-0002-3283-3192 0000-0002-2597-574X 0000-0002-8551-3598 0000-0002-0753-8853 0000-0003-2298-1623 0000-0001-8360-4376 0000-0002-9998-8578 |
| OpenAccessLink | https://doaj.org/article/98dd21f79d994f86970c1e24085dc434 |
| PMID | 32411943 |
| PQID | 2404051055 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_98dd21f79d994f86970c1e24085dc434 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7221402 hal_primary_oai_HAL_hal_04162817v1 proquest_miscellaneous_2404051055 pubmed_primary_32411943 crossref_citationtrail_10_1016_j_pulmoe_2020_05_002 crossref_primary_10_1016_j_pulmoe_2020_05_002 nii_cinii_1872835442659485056 elsevier_sciencedirect_doi_10_1016_j_pulmoe_2020_05_002 elsevier_clinicalkeyesjournals_1_s2_0_S2531043720301033 elsevier_clinicalkey_doi_10_1016_j_pulmoe_2020_05_002 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-07-01 |
| PublicationDateYYYYMMDD | 2020-07-01 |
| PublicationDate_xml | – month: 07 year: 2020 text: 2020-07-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Spain |
| PublicationPlace_xml | – name: Spain |
| PublicationTitle | Pediatric pulmonology |
| PublicationTitleAlternate | Pulmonology |
| PublicationYear | 2020 |
| Publisher | Elsevier España, S.L.U Informa UK Limited Wiley Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U Taylor & Francis Group |
| Publisher_xml | – name: Elsevier España, S.L.U – name: Informa UK Limited – name: Wiley – name: Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U – name: Taylor & Francis Group |
| References | Xu, Wu, Jiang, Xu, Ying, Ma (bib0070) 2020; 368 Tadolini, Codecasa, García-García, Blanc, Borisov, Alffenaar (bib0095) 2020 Akkerman, Aleksa, Alffenaar, Al-Marzouqi, Arias-Guillén, Belilovski (bib0105) 2019; 83 Esposito, Principi, CC Leung, Migliori (bib0085) 2020 Zhou, Yu, Du, Fan, Liu, Liu (bib0075) 2020; 395 Vitacca, Nava, Santus, Harari (bib0090) 2020 Multilobular infiltration, hypo-lymphocytosis, bacterial coinfection, smoking history, hyper-tension and age (MULBSTA) score. Borisov, Danila, Maryandyshev, Dalcolmo, Miliauskas, Kuksa (bib0100) 2019; 54 Chen, Zhou, Dong, Qu, Gong, Han (bib0120) 2020; 395 Guan, Ni, Hu, Liang, Ou, He (bib0065) 2020; 382 Leung, Lam, Cheng (bib0080) 2020; 24 Guo, Wei, Zhang, Wu, Li, Zhou (bib0115) 2019; 10 accessed 01.05.20 e_1_3_2_9_1 e_1_3_2_8_1 e_1_3_2_7_1 e_1_3_2_2_1 e_1_3_2_10_1 e_1_3_2_11_1 e_1_3_2_6_1 e_1_3_2_12_1 e_1_3_2_5_1 e_1_3_2_13_1 e_1_3_2_4_1 e_1_3_2_3_1 |
| References_xml | – year: 2020 ident: bib0085 article-title: Universal use of face masks for success against COVID-19: evidence and implications for prevention policies publication-title: Eur Respir J – volume: 382 start-page: 1708 year: 2020 end-page: 1720 ident: bib0065 article-title: Clinical characteristics of coronavirus disease 2019 in China publication-title: N Engl J Med – volume: 368 start-page: m606 year: 2020 ident: bib0070 article-title: Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-CoV-2) outside of Wuhan, China: retrospective case series publication-title: BMJ – reference: Multilobular infiltration, hypo-lymphocytosis, bacterial coinfection, smoking history, hyper-tension and age (MULBSTA) score. – volume: 395 start-page: 507 year: 2020 end-page: 513 ident: bib0120 article-title: Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study publication-title: Lancet – volume: 24 start-page: 364 year: 2020 end-page: 366 ident: bib0080 article-title: Let us not forget the mask in our attempts to stall the spread of COVID-19 publication-title: Int J Tuberc Lung Dis – year: 2020 ident: bib0095 article-title: Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases publication-title: Eur Respir J – reference: [accessed 01.05.20] – volume: 54 year: 2019 ident: bib0100 article-title: Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report publication-title: Eur Respir J – volume: 10 start-page: 2752 year: 2019 ident: bib0115 article-title: Clinical features predicting mortality risk in patients with viral pneumonia: the MuLBSTA score publication-title: Front Microbiol – volume: 395 start-page: 1054 year: 2020 end-page: 1062 ident: bib0075 article-title: Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study publication-title: Lancet – year: 2020 ident: bib0090 article-title: Early consensus management for non-ICU ARF SARS-CoV-2 emergency in Italy: from ward to trenches publication-title: Eur Respir J – volume: 83 start-page: 72 year: 2019 end-page: 76 ident: bib0105 article-title: Surveillance of adverse events in the treatment of drug-resistant tuberculosis: a global feasibility study publication-title: Int J Infect Dis – ident: e_1_3_2_6_1 doi: 10.1183/13993003.01260-2020 – ident: e_1_3_2_2_1 doi: 10.1056/NEJMoa2002032 – ident: e_1_3_2_5_1 doi: 10.5588/ijtld.20.0124 – ident: e_1_3_2_9_1 doi: 10.1183/13993003.01522-2019 – ident: e_1_3_2_8_1 doi: 10.1183/13993003.02328-2020 – ident: e_1_3_2_12_1 doi: 10.3389/fmicb.2019.02752 – ident: e_1_3_2_11_1 – ident: e_1_3_2_13_1 doi: 10.1016/S0140-6736(20)30211-7 – ident: e_1_3_2_10_1 doi: 10.1016/j.ijid.2019.03.036 – ident: e_1_3_2_3_1 doi: 10.1136/bmj.m606 – ident: e_1_3_2_4_1 doi: 10.1016/S0140-6736(20)30566-3 – ident: e_1_3_2_7_1 doi: 10.1183/13993003.00632-2020 |
| SSID | ssj0002002381 ssib044757603 ssj0009991 |
| Score | 2.645144 |
| Snippet | Little is known about the relationship between the COVID-19 and tuberculosis (TB). The aim of this study is to describe a group of patients who died with TB... AbstractLittle is known about the relationship between the COVID-19 and tuberculosis (TB). The aim of this study is to describe a group of patients who died... |
| SourceID | doaj pubmedcentral hal proquest pubmed crossref nii elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 233 |
| SubjectTerms | [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology Adult Age Distribution Aged Aged, 80 and over Antimalarials Antimalarials - therapeutic use Antitubercular Agents Antitubercular Agents - therapeutic use Betacoronavirus Cohort Studies Coinfection Coinfection - mortality Coronavirus Infections Coronavirus Infections - complications Coronavirus Infections - mortality Coronavirus Infections - therapy COVID-19 COVID-19; Infection control; Migrants; Mortality; Sequelae; TB; Adult; Age Distribution; Aged; Aged, 80 and over; Antimalarials; Antitubercular Agents; Betacoronavirus; Cohort Studies; Coinfection; Coronavirus Infections; Female; Humans; Hydroxychloroquine; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Retrospective Studies; Transients and Migrants; Tuberculosis, Pulmonary COVID-19; Infection control; Migrants; Mortality; Sequelae; TB; Adult; Age Distribution; Aged; Aged, 80 and over; Antimalarials; Antitubercular Agents; Betacoronavirus; COVID-19; Cohort Studies; Coinfection; Coronavirus Infections; Female; Humans; Hydroxychloroquine; Length of Stay; Male; Middle Aged; Noninvasive Ventilation; Oxygen Inhalation Therapy; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Transients and Migrants; Tuberculosis, Pulmonary COVID-19; TB; infection control; migrants; mortality; sequelae Diseases of the respiratory system Female Human health and pathology Humans Hydroxychloroquine Hydroxychloroquine - therapeutic use Infection control Length of Stay Life Sciences Male Middle Aged Migrants Mortality Noninvasive Ventilation Oxygen Inhalation Therapy Pandemics Pneumonia, Viral Pneumonia, Viral - complications Pneumonia, Viral - mortality Pneumonia, Viral - therapy Pulmonary and Respiratory Medicine RC705-779 Retrospective Studies SARS-CoV-2 Sequelae TB TB; COVID-19; Mortality; Migrants; Sequelae; Infection control Transients and Migrants Transients and Migrants - statistics & numerical data Tuberculosis, Pulmonary Tuberculosis, Pulmonary - complications Tuberculosis, Pulmonary - drug therapy Tuberculosis, Pulmonary - mortality |
| Title | Tuberculosis, COVID-19 and migrants: Preliminary analysis of deaths occurring in 69 patients from two cohorts |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2531043720301033 https://www.clinicalkey.es/playcontent/1-s2.0-S2531043720301033 https://dx.doi.org/10.1016/j.pulmoe.2020.05.002 https://cir.nii.ac.jp/crid/1872835442659485056 https://www.ncbi.nlm.nih.gov/pubmed/32411943 https://www.proquest.com/docview/2404051055 https://u-picardie.hal.science/hal-04162817 https://pubmed.ncbi.nlm.nih.gov/PMC7221402 https://doaj.org/article/98dd21f79d994f86970c1e24085dc434 |
| Volume | 26 |
| WOSCitedRecordID | wos000547603700009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Open Access Full Text customDbUrl: eissn: 2531-0437 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002002381 issn: 2531-0437 databaseCode: DOA dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2531-0437 dateEnd: 99991231 omitProxy: false ssIdentifier: ssib044757603 issn: 2531-0437 databaseCode: M~E dateStart: 20180101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 2531-0437 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0009991 issn: 2531-0437 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pb9MwFLboQIgL4ucIsMogjgRiJ25ibmNbNaRtTLCh3qzEdrZMbTIl7RAX_nbec5KqRZPKgUvU_HCc-H19_hw_f4-Qd5zbKE_i1NdBmvpRHglfZkHqZxrl7HId5EK7ZBPxyUkymcjTlVRfGBPWygO3DfdRJsZwlsfSSAl3Hck40Mw6YS6jo9ApgQLrWRlMXbnpNdcXYWY5AJmPAj79ujkX3HW9mM4qVMnkwYeVryp9v-Tk-9e6p8ElxkkOyqK4jYr-HVG50kWNH5GHHbeku-07PSZ3bPmE3D_uZs-fktnZIrO1Xkyrpmje072vP77s-0zStDR0VlzUGBLziZ7WdupSfdW_4EwrWUKrnBoki_BLa_xqWF7QoqQjSTth1obiQhU6_1lRzLlbz5tn5Hx8cLZ36HfpFnwdj0ZzX-dCGpPBiMuaMJRgJ8NYmGUiTY0OEp1KkwuWxBlK1pvIpDqJBBg2MhY4o7Dhc7JVVqV9QWhgImsSwSXq6zGZZMB7YOhk4lFmAQKhR8K-sZXutMgxJcZU9UFnV6o1kUITqUAoMJFH_GWp61aLY8P1n9GOy2tRSdsdAHypDl9qE748InoUqH6xKrhXuFGxofL4tnK26XxEo5hquArUd0QoApTj6DQIw9WSHQ1q6c0_1PkWYLr2voe7RwqPBUC8ecLiG-aRHUAxNDtuwZwouBcBT0PdHqTDHnnT41uBq8H5o7S01aJR0CgR-nAhPLLd4n1ZF_ByxmSED7_2T1h7mPUzZXHp5MxjzgFz_OX_sNYr8gDbo42nfk225vXC7pB7-mZeNPWQDOJJMnSeYkju7n8bnx_B3vHvgz_Z02kd |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tuberculosis%2C+COVID-19+and+migrants%3A+Preliminary+analysis+of+deaths+occurring+in+69+patients+from+two+cohorts&rft.jtitle=Pulmonology&rft.au=Motta%2C+I.&rft.au=Centis%2C+R.&rft.au=D%E2%80%99Ambrosio%2C+L.&rft.au=Garc%C3%ADa-Garc%C3%ADa%2C+J.-M.&rft.date=2020-07-01&rft.pub=Elsevier+Espa%C3%B1a%2C+S.L.U&rft.issn=2531-0437&rft.eissn=2531-0437&rft.volume=26&rft.issue=4&rft.spage=233&rft.epage=240&rft_id=info:doi/10.1016%2Fj.pulmoe.2020.05.002&rft.externalDocID=S2531043720301033 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F25310437%2FS2531043720X00043%2Fcov150h.gif |